Session speakers at the 2024 meeting of ISPOR—The Professional Society for Health Economics and Outcomes Research share their favorite parts of the conference. At the 2024 meeting of ISPOR—The ...

CHICAGO, May 13, 2025--(BUSINESS WIRE)--Tempus AI, Inc. (NASDAQ: TEM), a technology company leading the adoption of AI to advance precision medicine and patient care, has announced the presentation of ...

During a panel at Virtual ISPOR 2021, speakers presented global perspectives of COVID-19 vaccine rollout and efforts to target vaccine-hesitant communities. Lou Garrison, PhD, professor emeritus in ...

Leading Pharmaceutical Manufacturers, Contract Research Organizations, and Academic Medical Centers Collaborate on Global Research Project Using DistillerSR. OTTAWA, ONTARIO / ACCESS Newswire / August ...

Rob Abbott, CEO, ISPOR, highlights how emerging data strategies, advanced technology, and a renewed focus on patient needs are setting the direction for the next era of healthcare worldwide. In a ...

In response to ISPOR’s recently published 2026-2027 HEOR Trends, David Miller, CEO, Genesis Research Group, suggests that we’re no longer being evaluated on our ability to produce data, but on our ...

CAMBRIDGE, Mass.--(BUSINESS WIRE)--The collaborative Trajectory Analysis Project (cTAP), a multi-stakeholder, pre-competitive global coalition in Duchenne muscular dystrophy, today announced that ...

OneMedNet (ONMD) announced that it will demonstrate its next-generation iRWD platform at ISPOR Europe. Built on the Palantir (PLTR) Technologies Foundry ecosystem, the platform enables life sciences, ...

A look at evidence and value in a time of social and policy change. The International Society for Pharmacoeconomics & Outcomes Research (ISPOR) convened in Boston May 20-24, 2017 for its 22nd Annual ...

ISPOR - the professional society for health economics and outcomes research (HEOR), announced the publication of its 2020 Top 10 HEOR Trends report. In the report, the Society has identified the top ...